Final answer:
In acute myelogenous leukemia (AML), there is typically an impaired production of erythrocytes due to the overgrowth of abnormal myeloid cells in the bone marrow.
Step-by-step explanation:
Patients with acute myelogenous leukemia (AML) commonly experience impaired production of erythrocytes (red blood cells), rather than lymphocytes. AML is characterized by the rapid growth of abnormal myeloid cells that accumulate in the bone marrow and interfere with the production of normal blood cells, including erythrocytes. Since erythrocytes are produced in the bone marrow, their production is affected by the presence of these abnormal cells. The impaired production of red blood cells leads to anemia, which is a common symptom of AML.